Shasun Pharmaceuticals Ltd (SHAS.NS)

SHAS.NS on National Stock Exchange of India

200.50INR
10:54am IST
Price Change (% chg)

Rs0.75 (+0.38%)
Prev Close
Rs199.75
Open
Rs201.00
Day's High
Rs201.90
Day's Low
Rs200.25
Volume
35,910
Avg. Vol
945,411
52-wk High
Rs234.20
52-wk Low
Rs68.80

SHAS.NS

Chart for SHAS.NS

About

Shasun Pharmaceuticals Limited (SPL) is an India-based company. The Company is primarily engaged in manufacturing of Active Pharmaceutical Ingredients (API), their intermediates and finished dosage. The Company is also into product development and provides contract research and manufacturing services. The Company operates in... (more)

Overall

Beta: 1.28
Market Cap (Mil.): Rs11,961.64
Shares Outstanding (Mil.): 60.12
Dividend: 1.00
Yield (%): 0.50

Financials

  SHAS.NS Industry Sector
P/E (TTM): 37.26 33.49 34.41
EPS (TTM): 5.34 -- --
ROI: 6.84 18.10 17.37
ROE: 10.56 18.76 18.18
Search Stocks

Strides Arcolab to buy Shasun Pharma for $200 mln in all-stock deal

MUMBAI - Strides Arcolab Ltd has agreed to buy smaller rival Shasun Pharmaceuticals Ltd in an all-stock deal, valued at about $200 million, to bolster its generic medicine and drug ingredient businesses.

29 Sep 2014

UPDATE 1-India's Strides Arcolab to buy Shasun Pharma for $200 mln in all-stock deal

* Deal valued at about $200 mln based on Friday closing price

29 Sep 2014

India's Strides Arcolab to buy Shasun Pharma in all-stock deal

MUMBAI, Sept 29 - Indian generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal.

29 Sep 2014

UPDATE 3-Germany's Merck to buy Sigma-Aldrich for $17 bln to boost lab supplies operation

* Shares up 4 percent, outperforming sector index (Adds CEO comment, detail on pharma business)

22 Sep 2014

Earnings vs. Estimates

Search Stocks